Pertussis in Poland

International Journal of Epidemiology

Volumn 33, Issue 2, 2004, Pages 358-365

  Gzyl, Anna ^a   Augustynowicz, Ewa ^a   Rabczenko, Daniel ^a   Gniadek, Grzegorz ^a   Slusarczyk, Janusz ^a  

^a NATIONAL INSTITUTE OF HYGIENE   (Poland)

Author keywords

DTP; Pertussis; Poland

Indexed keywords

ACELLULAR VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; PERTUSSIS VACCINE;

DISEASE INCIDENCE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BORDETELLA PERTUSSIS; CHILD; CONTROLLED STUDY; DATA ANALYSIS; EPIDEMIOLOGICAL DATA; GEOGRAPHIC DISTRIBUTION; HOSPITALIZATION; HUMAN; IMMUNITY; INCIDENCE; INFANT; INFECTION CONTROL; INFECTION RISK; MAJOR CLINICAL STUDY; MONITORING; MORTALITY; PERTUSSIS; POLAND; PRIORITY JOURNAL; STATISTICAL ANALYSIS; VACCINATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; HUMANS; IMMUNIZATION SCHEDULE; INCIDENCE; INFANT; INFANT, NEWBORN; POLAND; SEASONS; WHOOPING COUGH;

EID: 2342581543     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/dyh012     Document Type: Article

References (27)

1. Matter HC. Pertussis surveillance in Switzerland, 1992 to 1997 - a large epidemic in 1994. What next? Euro Surveill 1999;4:130-33.
2. Centers for Disease Control. Pertussis Deaths - United States, 2000. MMWR 2002;51(28):616.
3. De Melker HE, Schellekens JF, Neppelenbroek SE, Mooi FR, Rumke HC, Conyn-van Spaendonck MA. Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Infect Dis 2000;6:348-57.
4. Hallander HO, Olin P. Marked decline in pertussis followed reintroduction of pertussis vaccination in Sweden. Euro Surveill 1999;4:128-29.
5. Gangarosa EJ, Galazka AM, Wolfe CR et al. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet 1998;351:356-61.
6. Mooi FR, van Oirschot H, Heuvelman K, van der Heide HG, Gaastra W, Willems RJ. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun 1998;66:670-75.
7. Mooi FR, He Q, van Oirschot H, Mertsola J. Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland. Infect Immun 1999;67:3133-34.
8. Cassiday P, Sanden G, Heuvelman K, Mooi F, Bisgard KM, Popovic T. Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. J Infect Dis 2000;182:1402-08.
9. Nelson JD. The changing epidemiology of pertussis in young infants. The role of adults as reservoirs of infection. Am J Dis Child 1978;132:371-73.
10. Gzyl A, Augustynowicz E, van Loo I, Slusarczyk J. Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland. Vaccine 2000;20:299-303.
11. Yih WK, Lett SM, des Vignes FN, Garrison KM, Sipe PL, Marchant CD. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. J Infect Dis 2000;182:1409-16.
12. Guris D, Strebel PM, Bardenheier B et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999;28:1230-37.
13. de Melker HE, Conyn-van Spaendonck MA, Rumke HC, van Wijngaarden JK, Mooi FR, Schellekens JF. Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine. Emerg Infect Dis 1997;3:175-78.
14. Rocznik Statystyczny 1997. (Statistical yearbook of the Republic of Poland 1997.) Central Statistic Office ZWS, 1997.
15. Rocznik Statystyczny 1998. (Statistical yearbook of the Republic of Poland 1998.) Central Statistic Office ZWS, 1998.
16. Methodical Materials. Warsaw: National Institute of Hygiene, 1987:33.
17. Draper NR, Smith H. Applied Regression Analysis. New York: John Wiley and Sons, Inc., 1966.
18. Hochberg Y, Tambane A. Multiple Comparison Procedures. New York: John Wiley and Sons, Inc., 1987.
19. Splus User's Guide. Data Analysis Products Division. Math Soft. Washington: Seattle, 1999.
20. Brennan M, Strebel P, George H et al. Evidence for transmission of pertussis in schools, Massachusetts, 1996: epidemiologic data supported by pulsed-field gel electrophoresis studies. J Infect Dis 2000;181:210-15.
21. Strebel P, Nordin J, Edwards K et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. J Infect Dis 2001;183:1353-59.
22. De Serres G, Shadmani R, Duval B et al. Morbidity of pertissis in adolescents and adults. J Infect Dis 2000;182:174-79.
23. Heininger U. Recent progress in clinical and basic pertussis research. Eur J Pediatr 2001;160:203-13.
24. Slusarczyk J, Dulny G, Nowak K et al. Immunity of children aged 6-8 against pertussis, tetanus and diphtheria. Przegl Epidemiol 2002;56:39-48 (in Polish).
25. WHO Recommended Surveillance Standards. WHO/CDC/CSR/ISR/99.2;1999:89.
26. Dulny G, Nowak K. Clinical diagnosis of pertussis - problems with laboratory confirmation. Przegl Epidemiol 1998;52(Suppl.1):58 (abstract in English).
27. Dulny G, Zabicki W. Pertussis recognition. Przegl Epidemiol 1997;51:475-77 (abstract in English).